EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy

Francesca Melle, Dhruv Menon, João Conniot, Jon Ostolaza-Paraiso, Sergio Mercado, Jhenifer Oliveira, Xu Chen, Bárbara B Mendes, João Conde, David Fairen-Jimenez iD

Advanced Materials · 2025-12 · 37 (52)

DOI: 10.1002/adma.202412757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.02.2025. Verfasst von Francesca Melle und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Adsorption & Advanced Materials Laboratory (AAML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett …. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Pancreatic Neoplasms, Machine Learning, Antineoplastic Agents. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC, HORIZON EUROPE European Research Council, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite improvements in cancer survival rates, metastatic and surgery‐resistant cancers, such as pancreatic cancer, remain challenging, with poor prognoses and limited treatment options. Enhancing drug bioavailability in tumors, while minimizing off‐target effects, is crucial. Metal–organic frameworks (MOFs) have emerged as promising drug delivery vehicles owing to their high loading capacity, biocompatibility, and functional tunability. However, the vast chemical diversity of MOFs complicates the rational design of biocompatible materials. This study employed machine learning and molecular simulations to identify MOFs suitable for encapsulating gemcitabine, paclitaxel, and SN‐38, and identified PCN‐222 as an optimal candidate. Following drug loading, MOF formulations are improved for colloidal stability and biocompatibility. In vitro studies on pancreatic cancer cell lines have shown high biocompatibility, cellular internalization, and delayed drug release. Long‐term stability tests demonstrated a consistent performance over 12 months. In vivo studies in pancreatic tumor‐bearing mice revealed that paclitaxel‐loaded PCN‐222, particularly with a hydrogel for local administration, significantly reduced metastatic spread and tumor growth compared to the free drug. These findings underscore the potential of PCN‐222 as an effective drug delivery system for the treatment of hard‐to‐treat cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksPancreatic NeoplasmsMachine LearningAntineoplastic AgentsDrug CarriersAnimalsHumansCell Line, TumorPaclitaxelMiceGemcitabineDeoxycytidineDrug LiberationIrinotecan

Stichwörter der Autor:innen

drug deliverymachine learningmetal–organic frameworkspancreatic cancerporous materials

Substanzen

Metal-Organic FrameworksPaclitaxelGemcitabineDeoxycytidineAntineoplastic AgentsDrug CarriersIrinotecan

Autor:innen und Institutionen

  • The Adsorption & Advanced Materials Laboratory (AAML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK.
  • NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Comprehensive Health Research Centre (CHRC), NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.

ORCID-Profile: David Fairen-Jimenez

Förderung

  • EPSRC
  • HORIZON EUROPE European Research Council
  • Engineering and Physical Sciences Research Council
  • European Research Council
  • FCT - Fundação Ciência e a Tecnologia

Zitieren

APA

Melle, F., Menon, D., Conniot, J., Ostolaza-Paraiso, J., Mercado, S., Oliveira, J., Chen, X., Mendes, B. B., Conde, J., & Fairen-Jimenez, D. (2025). Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy. Advanced Materials, 37(52). https://doi.org/10.1002/adma.202412757

Vancouver

Melle F, Menon D, Conniot J, Ostolaza-Paraiso J, Mercado S, Oliveira J, et al. Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy. Advanced Materials. 2025;37(52). doi:10.1002/adma.202412757

BibTeX
@article{Melle2025,
  author = {Melle, Francesca and Menon, Dhruv and Conniot, João and Ostolaza-Paraiso, Jon and Mercado, Sergio and Oliveira, Jhenifer and Chen, Xu and Mendes, Bárbara B and Conde, João and Fairen-Jimenez, David},
  title = {Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {52},
  doi = {10.1002/adma.202412757}
}
Kostenlos starten →